Annie M Young

Summary

Affiliation: University of Birmingham
Country: UK

Publications

  1. ncbi Can pharmacokinetic monitoring improve clinical use of fluorouracil?
    A M Young
    CRC Institute of Cancer Studies, University of Birmingham, Edgbaston, England
    Clin Pharmacokinet 36:391-8. 1999
  2. ncbi A patient preference study comparing raltitrexed ('Tomudex') and bolus or infusional 5-fluorouracil regimens in advanced colorectal cancer: influence of side-effects and administration attributes
    A Young
    CRC Institute for Cancer Studies, University of Birmingham, UK
    Eur J Cancer Care (Engl) 8:154-61. 1999
  3. ncbi Prospective randomized comparison of dacarbazine (DTIC) versus DTIC plus interferon-alpha (IFN-alpha) in metastatic melanoma
    A M Young
    CRC Trials Unit, Institute of Cancer Studies, The Medical School, Edgbaston, Birmingham, UK
    Clin Oncol (R Coll Radiol) 13:458-65. 2001
  4. ncbi Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial
    Annie M Young
    Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
    Lancet 373:567-74. 2009

Detail Information

Publications4

  1. ncbi Can pharmacokinetic monitoring improve clinical use of fluorouracil?
    A M Young
    CRC Institute of Cancer Studies, University of Birmingham, Edgbaston, England
    Clin Pharmacokinet 36:391-8. 1999
    ....
  2. ncbi A patient preference study comparing raltitrexed ('Tomudex') and bolus or infusional 5-fluorouracil regimens in advanced colorectal cancer: influence of side-effects and administration attributes
    A Young
    CRC Institute for Cancer Studies, University of Birmingham, UK
    Eur J Cancer Care (Engl) 8:154-61. 1999
    ..Such preferences should constitute an important part of decisions relating to the choice of chemotherapy regimen in ACRC...
  3. ncbi Prospective randomized comparison of dacarbazine (DTIC) versus DTIC plus interferon-alpha (IFN-alpha) in metastatic melanoma
    A M Young
    CRC Trials Unit, Institute of Cancer Studies, The Medical School, Edgbaston, Birmingham, UK
    Clin Oncol (R Coll Radiol) 13:458-65. 2001
    ..These results are inconclusive primarily owing to the small size of the trial. A meta-analysis is required to determine whether there is a role for the addition of IFN-alpha to DTIC in the treatment of this disease...
  4. ncbi Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial
    Annie M Young
    Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
    Lancet 373:567-74. 2009
    ..We therefore assessed whether warfarin reduces catheter-related thrombosis compared with no warfarin and whether the dose of warfarin determines the thromboprophylactic effect...